Àíåñòåçèîëîãèÿ è ðåàíèìàòîëîãèÿ ¹6 2008

ßðóáöåâè÷ Ð. Ý., Ñïàñ Â. Â., Øàïåëü È. À., Êóçíåöîâ Î. Å.

Âîçìîæíîñòè ýëèìèíàöèè âîñïàëèòåëüíûõ ìåäèàòîðîâ ïðè ñåïñèñå ñ ïîìîùüþ ñîðáöèîííûõ ìåòîäîâ äåòîêñèêàöèè

ËÈÒÅÐÀÒÓÐÀ
1. Êèðêîâñêèé Â. Â. Äåòîêñèêàöèîííàÿ òåðàïèÿ ïðè ïåðèòîíèòå. Ìèíñê, 1997.
2. Ñèìáèðöåâ À. Ñ. Öèòîêèíû: êëàññèôèêàöèÿ è áèîëîãè÷åñêèå ôóíêöèè // Öèòîêèíû è âîñïàëåíèå. — 2004. — ¹ 2. — Ñ. 31—37.
3. ßêóáöåâè÷ Ð. Ý., Ñïàñ Â. Â., Øàïåëü È. À. è äð. Âîçìîæíîñòè àíòèïðîòåèíàçíîé ãåìîñîðáöèè è èíòåíñèâíîé òåðàïèè àáäîìèíàëüíîãî ñåïñèñà // Âåñò. èíòåíñ. òåð. — 2002. — ¹ 5. — Ñ. 140—144.
4. Adrie C., Pinsky M. R. The Inflammatory Balance in Human Sepsis // Intens. Care Med. — 2000. — Vol. 26. — P. 364—375.
5. Aoiki H., Kodama M., Tani T. et al. Treatment of Sepsis by Extracorporeal Elimination of Endotoxin Using Polemyxin B-immobilized Fiber // Am. J. Surg. — 1994. — Vol. 167, N 4. — P. 412—417.
6. Bellomo R., Honore P. M., Matson J. et al. Extracorporeal Blood Treatment Methods in SIRS/Sepsis // Int. J. Artif. Organs. — 2005. — Vol. 28, N 5. — P. 450—458.
7. Bellomo R., Tipping P., Boyce N. Continuous Veno-Venous Hemofiltration With Dialysis Removes Cytokines From the Circulation of Septic Patients // Crit. Care Med.— 1993. — Vol. 21, N 4. — P. 522—526.
8. Blackwell T. S., Christman J. W. Sepsis and Cytokines: Current Status. // Brit. J. Anaesth. — 1996. — Vol. 77. — P. 110—117.
9. Dellinger R. P., Carlet J. M., Masur H. et al. Surviving Sepsis Campaign Guidelines for Management of Severe Sepsis and Septic Shock // Intens. Care Med. — 2004. — Vol. 30, N 4. — P. 536—555.
10. Hotchkiss R. S., Karl I. E. Medical Progress: the Pathophysiology and Treatment of Sepsis // New Engl. J. Med. — 2003. — Vol. 348. — P. 138—150.
11. Kellum J. A., Dishart M. K. Effect of Hemofiltration Filter Adsorption on Circulating IL-6 Levels in Septic Rats // Crit. Care. — 2002. — Vol. 6, N 5. — P. 429—433.
12. Kellum J. A., Song M., Venkataraman R. Hemoadsorption Removes Tumor Necrosis Factor, IL-6 and IL-10, Reduces Nuclear Factor-kappa B DNA Binding, and Improves Short-Term Survival in Lethal Endotoxemia // Crit. Care Med. — 2004. — Vol. 32, N 3. — P. 801—805.
13. Kushi H., Miki T., Nakahara J. Hemoperfusion with an immobilized polymyxin B column reduces the blood level of neutrophil elastase // Blood Purif. — 2006. — Vol 24, N 2. — P. 212—217.
14. Reeves J. H. A Review of Plasma Exchange in Sepsis // Blood Purif. — 2002. — Vol. 20, N 3. — P. 282—288.
15. Ronco C. The Place of Early Haemoperfusion with Polymyxin the Treatment of Sepsis // Crit. Care. — 2005.- Vol. 9, N 6. — P. 631—633.
16. Ronco C., Brendolan A., Dan M. et al. Adsorption in Sepsis // Kidney Int. Suppl. — 2000. — Vol. 76. — P. 148—155.
17. Ronco C., Brendolan A., Lonnemann G. et al. A Pilot Study of Coupled Plasma Filtration with Adsorption in Septic Shock // Crit. Care Med. — 2002. — V. 30, N 5. — P. 1250—1255.
18. Sander A., Armruster W., Sander B. Hemofiltration Increased IL-6 Clearance in Early Systemic Inflammatory response Syndrome but Does Not Alter IL-6 and TNF-alpha Plasma Concentration // Intens. Care Med. — 1997. — Vol. 23, N 8. — P. 878—884.
19. Shoji H. Extracorporeal Endotoxin Removal for the Treatment of Sepsis: Endotoxin Adsorption Cartridge (Toraymyxin) // Ther. Apher. Dial. — 2003. — Vol. 7, N 1. — P. 108—114.
20. Song M., Winchester J., Albright R. L. et al. Cytokine Removal with a Novel Adsorbent Polymer // Blood Purif. — 2004. — Vol. 22, N 5. — P. 428—434.
21. Tetta C., Bellomo R., D Intini V. et al. Do Circulating Cytokines Really Matter in Sepsis? // Kidney Int. — 2003. — Vol. 63. — P. 69—71.
22. Tetta C., Gavaillon J. M., Schulze M. et al. Removal of Cytokines and Activated Complement Components in an Esxperimental Model of Continuous Plasma Filtration Coupled with Sorbent Adsorption // Nephrol. Dial. Transplant. — 1998. — Vol. 13, N 6. — P. 1458—1464.
23. Vincent J. L., Abraham E. The Last 100 Years of Sepsis // Am. J. of Respir. And Crit. Care Med. — 2006. — Vol. 173. — P. 256—263.